Tag Archives: HCCI

Hot Warren Buffett Stocks For 2021

Stocks discussed on the Lightning Round segment of Jim Cramer’s Mad Money Program, Monday, December 12.

Bullish Calls

Gilead (NASDAQ:GILD): Not likely to sell it, and could be a buy.

CyberArk (NASDAQ:CYBR): Bullish on stock.

Smith & Wesson (NASDAQ:SWHC): Stock appears cheap.

Bearish Calls

Ford (NYSE:F): Cramer said Ford is a good company, but GM (NYSE:GM) has better momentum. Also, Ford is in the crosshairs of incoming president Donald Trump.

PolyOne (NYSE:POL): Cramer likes the chemicals business, but his pick in the sector is Dow (NYSE:DOW).

Hot Warren Buffett Stocks For 2021: Bioanalytical Systems, Inc.(BASI)

Bioanalytical Systems, Inc., incorporated on July 17, 1975, is an international contract research organization providing drug discovery and development services and analytical instruments. The Company’s clients and partners include pharmaceutical, biotechnology, academic and government organizations. The Company derives its revenues from sales of its research services and drug development tools. The Company supports the preclinical and clinical development needs of researchers and clinicians for small molecule and biomolecule drug candidates. The Company’s principal clients are scientists engaged in analytical chemistry, drug safety evaluation, clinical trials, drug metabolism studies, pharmacokinetics and basic research from small start-up biotechnology companies to many of the global pharmaceutical companies. The Company operates in two business segments: contract research services and research products, both of which addresses the bioanalytical, preclinical, and clinical research needs of drug developers.

Services

This segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. Product Characterization, Method Development, and Validation: Analytical methods, primarily performed in West Lafayette, Indiana, determine potency, purity, chemical composition, structure, and physical properties of a compound. Bioanalytical Testing: The Company analyzes specimens from preclinical and clinical trials to measure drug and metabolite concentrations in complex biological matrices. Bioanalysis is performed at its facilities in West Lafayette, Indiana. Stability Testing: The Company tests stability of drug substances and formulated drug products, and maintains storage facilities in West Lafayette, Indiana. In Vivo Pharmacology: The Company provides preclinical in vivo sampling services for the continuous monitoring of chemical changes in life, in particular, how a drug enters, travels thr! ough, and is metabolized in living systems. Those services are performed in customized facilities in West Lafayette and Evansville, Indiana using its robotic Culex Automated Pharmacology System. Preclinical and Pathology Services: The Company provides pharmacokinetic and safety testing in studies ranging from acute safety monitoring of drugs and medical devices to chronic, multi-year oncogenicity studies in its Evansville, Indiana site.

Research Products

This segment designs, develops, manufactures, and markets in vivo sampling systems and accessories (including disposables, training, and systems qualification); physiology monitoring tools; and liquid chromatography and electrochemistry instruments platforms. Analytical Products: The analytical products consist of the Company’s liquid chromatographic and electrochemical instruments with associated accessories. The critical component of these products is the Epsilon electrochemical platform. The market is principally academic institutions and industrial research companies. In vivo Sampling Products: The in vivo sampling products consist of the Culex family of automated in vivo sampling and dosing instruments. These are used by pharmaceutical researchers to dose animals and collect biological samples (blood, bile, urine, microdialysate, feces or any bio-fluid) from the animals. The Culex products offer reduction in test model use and comparable reduction in labor. The line also includes in vivo sampling devices sold to drug developers and medical research centers to assist in the study of various medical conditions, including stroke, depression, Alzheimer’s and Parkinson’s diseases, diabetes, and osteoporosis. Vetronics’ Products: The Vetronics’ products consist of instruments and related software to monitor and diagnose cardiac function (electro-cardiogram), and measure other vital physiological parameters primarily in cats and dogs in veterinary clinics.

The Company competes with Covance, Inc.; Pharmaceut! ical Prod! uct Development, Inc.; Charles River Laboratories, Inc., and Quintiles Transnational Holdings, Inc.

Advisors’ Opinion:

  • [By Max Byerly]

    Headlines about Bioanalytical Systems (NASDAQ:BASI) have been trending positive this week, according to Accern. The research firm scores the sentiment of media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Bioanalytical Systems earned a news sentiment score of 0.27 on Accern’s scale. Accern also gave media headlines about the company an impact score of 47.5882570492565 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Hot Warren Buffett Stocks For 2021: Heritage-Crystal Clean, Inc.(HCCI)

Heritage-Crystal Clean, Inc., through its subsidiary, Heritage-Crystal Clean, LLC, provides parts cleaning, and hazardous and non-hazardous waste services to small and mid-sized customers in the manufacturing and vehicle maintenance sectors. It operates in two segments: Environmental Services and Oil Business. The Environmental Services segment offers parts cleaning, containerized waste management, vacuum truck, and antifreeze recycling services. This segment also provides oily water disposal and treatment, oil filter recycling, on-site cleaning, and waste management services, as well as sells solvents, machines, absorbents, and accessories. The Oil Business segment collects used oil and sells recycled fuel oil, as well as engages in the re-refining of used oil into lubricant base oil and by-products. This segment also collects and disposes waste water. As of January 03, 2015, the company operated through 84 branches serving approximately 100,000 customer locations. Heritage-Crystal Clean, Inc. was incorporated in 2007 and is headquartered in Elgin, Illinois.

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Heritage-Crystal Clean Inc  (NASDAQ:HCCI)Q4 2018 Earnings Conference CallMarch 06, 2019, 10:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Shares of Heritage-Crystal Clean, Inc. (NASDAQ:HCCI) have received a consensus rating of “Buy” from the nine ratings firms that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and six have given a buy recommendation to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $25.40.

Hot Warren Buffett Stocks For 2021: Revlon, Inc.(REV)

Revlon, Inc., incorporated on April 24, 1992, manufactures, markets and sells around the world a range of beauty and personal care products, including color cosmetics, hair color, hair care and hair treatments, as well as beauty tools, men’s grooming products, anti-perspirant deodorants, fragrances, skincare and other beauty care products. The Company operates through three segments: Consumer, Professional and Other. The Company conducts its business through its operating subsidiary, Revlon Consumer Products Corporation (Products Corporation) and its subsidiaries.

The Company maintains separate Websites, including www.revlon.com, www.almay.com, www.revloncolorsilk.com, www.revlonprofessional.com, www.americancrew.com, www.cnd.com and www.mitchum.com, dedicated to the Revlon, Almay, Revlon ColorSilk, Revlon Professional, American Crew, CND and Mitchum brands, respectively. Each of these Websites feature product and promotional information for the brands. The Company operates a research and development facility in Edison, New Jersey for products within its Consumer segment. The Company has research facilities for its products within the Professional segment in the United States (in California and Florida), Spain and Mexico. The Company’s principal customers for its Consumer segment include large volume retailers and chain drug stores, including retailers, such as Walmart, CVS and Target in the United States, Shoppers DrugMart in Canada, A.S. Watson & Co. retail chains in Asia Pacific and Europe and Walgreens Boots Alliance in the United States and the United Kingdom Walmart and its affiliates around the world. The Company’s principal customers for its Professional segment include Beauty Systems Group, Salon Centric and Ulta Salon, Cosmetics and Fragrance, as well as individual hair and nail salons and other distributors to professional salons.

Consumer Segment

The Company’s Consumer segment includes cosmetics, hair color and hair care, beauty tools, anti-perspirant! deodorants, fragrances and skincare products sold in approximately 130 countries in large volume retailers, chain drug and food stores, chemist shops, hypermarkets, general merchandise stores, the Internet/e-commerce, television shopping, department stores, one-stop shopping beauty retailers, specialty cosmetics stores and perfumeries in the United States and internationally. The Company manufactures and markets a range of cosmetics, including face, lip, eye and nail products. The Company sells a range of cosmetics under its Revlon brand, which are designed to fulfill consumer wants and needs, and are principally priced in the upper range for large volume retailers. The Revlon brand consists of face makeup, including foundation, powder, blush and concealers; lip makeup, including lipstick, lip gloss and lip liner; eye makeup, including mascaras, eyeliners, eye shadows and brow products, and nail color and nail care lines. Its franchises within the Revlon brand include Revlon ColorStay, which offers consumers a range of products with long-wearing technology; Revlon PhotoReady products that are offered in face and eye makeup and are designed with photochromatic pigments that bend and reflect light; Revlon Age Defying, which consists of face makeup for women in the over-35 age bracket, with ingredients to help reduce the appearance of fine lines and wrinkles; Revlon Super Lustrous, which is the Company’s wax-based lipcolor and is offered in a range of shades of lipstick and lip gloss, and Revlon Mascara, which consists of a collection of over five mascaras, each with a lash benefit, including lash definition, length, volume, magnified volume and length, and an all-in-one formula.

The Company’s Almay brand consists of hypo-allergenic, dermatologist-tested, fragrance-free cosmetics and skincare products. The Almay brand consists of face makeup, including foundation, pressed powder, primer and concealer; eye makeup, including eye shadows, mascaras and eyeliners; lip makeup, and makeup removers. ! Franchise! s within the Almay brand include Almay Smart Shade in face; Almay Intense i-Color in eye, and Almay Color + Care in lip. The Company’s SinfulColors and Pure Ice brands consist primarily of nail enamels, available in various bold, vivid and on-trend colors.

The Company sells both hair color and hair care products throughout the world to large volume retailers and other retailers, primarily under the Company’s Revlon ColorSilk franchise, as well as under the premium priced Llongueras brand in Spain. Revlon ColorSilk products provide radiant, long-lasting color that leaves hair nourished, hydrated and ultra-conditioned. The Company sells Revlon beauty tools, which include nail, eye and manicure and pedicure grooming tools, eye lash curlers and a full line of makeup brushes under the Revlon brand name. The Company sells a selection of fragrances, including perfumes, eau de toilettes, colognes and body sprays. The Company’s portfolio includes fragrances under globally-recognized brand names, such as Charlie and Jean Nate. The Company sells Mitchum anti-perspirant deodorant products for men and women, with ingredients that provide consumers with approximately 48 hours of protection. The Company sells skincare products in the United States and in global markets under various regional brands, including the Company’s Natural Honey and Gatineau brands.

Professional Segment

The Company’s Professional segment includes a line of products sold to hair and nail salons, and professional salon distributors, including hair color, shampoos, conditioners, styling products, nail polishes and nail enhancements. The Professional segment also includes a multi-cultural line sold in both professional salons, large volume retailers and other retailers. The Company’s Revlon Professional brand includes hair color, hair care and hair treatment products that are distributed to professional salons, salon professionals and salon distributors, and sold in over 60 countries. Revlon Professional salo! n product! s include Revlonissimo NMT, Nutri Color Creme, Sensor Perm and Revlon Professional Equave.

The Company sells men’s shampoos, conditioners, gels and other hair care, and grooming products for use and sale by professional salons under the American Crew brand name. American Crew is sold in over 30 countries. The Company also sells unisex hair products under the d:fi brand, which is a value-priced full line of cleansing, conditioning and styling products. The Company sells nail enhancement systems and nail color and treatment products and services for use by the professional nail salon industry under the CND brand name. CND offers professional nail, hand and foot care products, and CND-branded products are sold in over 75 countries. CND nail products include CND Shellac brand 14+ day nail color system, which delivers 14+ days of flawless wear, superior color and mirror shine with zero dry-time and no nail damage, and CND Vinylux weekly polish, a nail polish that uses a patent-pending technology and lasts approximately a week. While ordinary polishes become brittle and deteriorate over time, CND Vinylux dries with exposure to natural light to a flawless finish and strengthens its resistance to chips over time. The Company also sells professional hair products under brand names, such as Orofluido, UniqOne and Intercosmo. The Company sells multi-cultural hair-care products to professional salons, large volume retailers and other retailers, primarily in the United States under the Creme of Nature brand.

Other Segment

The Company’s Other segment primarily includes the distribution of prestige, designer and celebrity fragrances, cosmetics and skincare products, such as Burberry and Rihanna branded products. The Other segment includes the operating results of the CBB business, which develops, manufactures, markets and distributes fragrances, and other beauty products, principally through department stores and selective distribution in international territories.

T! he Compan! y competes with L’Oreal S.A., The Procter & Gamble Company, Avon Products, Inc., Coty, Inc., Shiseido Co., Johnson & Johnson, Kao Corp., Henkel AG & Co., Mary Kay Inc., Hand & Nail Harmony, Inc., Oriflame Holding AG, Markwins International Corporation, LVMH Moet Henessy Louis Vuitton SE, Elizabeth Arden, Inc., Boots UK Limited and The Estee Lauder Companies Inc.

Advisors’ Opinion:

  • [By Max Byerly]

    Revlon (NYSE:REV) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a report issued on Tuesday.

  • [By Max Byerly]

    An issue of Revlon Inc (NYSE:REV) bonds fell 2% as a percentage of their face value during trading on Thursday. The high-yield debt issue has a 5.75% coupon and will mature on February 15, 2021. The debt is now trading at $80.50 and was trading at $84.88 one week ago. Price moves in a company’s bonds in credit markets often anticipate parallel moves in its share price.

  • [By Logan Wallace]

    News headlines about Revlon (NYSE:REV) have been trending somewhat positive recently, according to Accern Sentiment. The research group rates the sentiment of media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Revlon earned a news sentiment score of 0.16 on Accern’s scale. Accern also assigned news stories about the company an impact score of 47.276202232048 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Hot Warren Buffett Stocks For 2021: Kura Oncology, Inc.(KURA)

We are a clinical stage biopharmaceutical company discovering and developing personalized therapeutics for the treatment of solid tumors and blood cancers. We focus on the development of small molecule product candidates that target cell signaling pathways that are important to driving the progression of certain cancers. We aim to employ molecular diagnostics to identify patients with cancers who are likely to benefit from our targeted product candidates.
Advancements in cancer genetics and new molecular diagnostic tools are helping define why some patients respond to a particular therapy while other patients receive little to no clinical benefit. This new era in cancer drug discovery and development offers the potential for innovative treatments that are safer and more effective for patients with particular cancers.   Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Kura Oncology, Inc.  (NASDAQ:KURA)Q4 2018 Earnings Conference CallMarch 05, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    BidaskClub lowered shares of Kura Oncology (NASDAQ:KURA) from a hold rating to a sell rating in a research note issued to investors on Tuesday morning.

  • [By Shane Hupp]

    Kura Oncology (NASDAQ:KURA) was the target of unusually large options trading on Thursday. Stock investors bought 699 put options on the company. This represents an increase of 694% compared to the typical daily volume of 88 put options.

Hot Warren Buffett Stocks For 2021: TRACON Pharmaceuticals, Inc.(TCON)

TRACON Pharmaceuticals, Inc., incorporated on October 28, 2004, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics for cancer, wet age-related macular degeneration (wet AMD) and fibrotic diseases. The Company’s research focuses on antibodies that bind to the endoglin receptor, which is essential to angiogenesis (the process of new blood vessel formation) and a contributor to fibrosis (tissue scarring). The Company’s lead product candidate, TRC105, is an endoglin antibody that is being developed for the treatment of multiple solid tumor types in combination with inhibitors of the vascular endothelial growth factor (VEGF) pathway. TRC205 is being developed for the treatment of fibrotic disease. The Company is also developing TRC102, a small molecule that is in clinical development for the treatment of lung cancer and glioblastoma.

TRC105

The Company is developing TRC105 for use in combination with agents that inhibit angiogenesis by targeting the VEGF pathway. VEGF is required for angiogenesis. TRC105 binds to the endoglin receptor at a precise location to inhibit endothelial cell activation and angiogenesis. TRC105 has been studied in over six completed Phase II clinical trials and approximately three completed Phase I clinical trials, and is being dosed in over five Phase II clinical trials. TRC105 is focused on approximately two orphan indications, gestational trophoblastic neoplasia (GTN) and angiosarcoma. The next tier of development includes ongoing Phase II trials in renal cell carcinoma, glioblastoma and hepatocellular carcinoma. The Company has produced formulations of TRC105 for development in ophthalmology, which are developed for the treatment of wet AMD, the cause of blindness in the Western world.

TRC205

The Company’s TRC205 is a humanized, deimmunized anti-endoglin antibody. TRC205 is being developed for the treatment of fibrotic diseases, including nonalcoholic ! steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF).

TRC102

The Company is developing TRC102 (methoxyamine hydrochloride) to reverse resistance to specific chemotherapeutics by inhibiting base excision repair (BER). TRC102 interrupts BER by binding within apurinic/apyrimidinic (AP) sites, converting the AP site to a substrate for the enzyme topoisomerase II, which cleaves TRC102-bound deoxy ribonucleic acid (DNA), resulting in an accumulation of DNA strand breaks that trigger cellular apoptosis or programmed cell death. TRC102 is being developed to reverse resistance to Temodar, an alkylating chemotherapeutic, as well as to Alimta and Fludara, two antimetabolite chemotherapeutics. TRC102 began Phase II development through a Phase II clinical trial that combines TRC102 in patients with mesothelioma, as well as a Phase II clinical trial of TRC102 in patients with glioblastoma.

The Company competes with Pfizer, Inc., Acceleron Pharma Inc., Amgen, Inc., MedImmune LLC, OncoMed Pharmaceuticals Inc., Regeneron Pharmaceuticals, Inc., Roche AG, Genfit Corp., Intercept Pharmaceuticals, Inc., Conatus Pharmaceuticals Inc., Galmed Medical Research Ltd., Gilead Sciences, Inc., Immuron Ltd., Shire plc, Mochida Pharmaceutical Co., Ltd., NasVax Ltd., Raptor Pharmaceutical Corp., Takeda Pharmaceutical Company Limited, InterMune, Inc., Boehringer Ingelheim, Biogen Idec., Bristol-Myers Squibb, Celgene Corporation, Fibrogen, Inc., Gilead, Janssen Pharmaceuticals Inc., Novartis AG, Sanofi S.A, Tesaro, Inc. and AbbVie Inc.

Advisors’ Opinion:

  • [By Stephan Byrd]

    TRACON Pharmaceuticals Inc (NASDAQ:TCON) fell 12.3% during trading on Wednesday . The company traded as low as $1.23 and last traded at $1.21. 896,880 shares changed hands during trading, an increase of 112% from the average session volume of 422,831 shares. The stock had previously closed at $1.38.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on TRACON Pharmaceuticals (TCON)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Small Cap Stocks To Own Right Now

Small cap fitness device stock and wearables stock Fitbit Inc (NYSE: FIT) started off as a high flyer after its 2015 IPO, but those highflying days have largely ended as you can see from its long term performance chart:

Fitbit Inc also reported Q4 earnings yesterday that were below expectations with the earnings report noting:

Best Small Cap Stocks To Own Right Now: Nexstar Broadcasting Group Inc.(NXST)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Nexstar Media Group (NASDAQ: NXST) and Liberty Media Formula One Series C (NASDAQ:FWONK) are both mid-cap consumer discretionary companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, profitability and risk.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Nexstar Media Group (NXST)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Nexstar Media Group Inc (NASDAQ:NXST) – Research analysts at B. Riley decreased their Q3 2018 EPS estimates for Nexstar Media Group in a research note issued on Thursday, September 6th. B. Riley analyst B. Crockett now anticipates that the company will post earnings per share of $2.07 for the quarter, down from their previous estimate of $2.19. B. Riley currently has a “Buy” rating and a $92.00 price objective on the stock. B. Riley also issued estimates for Nexstar Media Group’s Q4 2018 earnings at $3.22 EPS, FY2018 earnings at $8.14 EPS, FY2019 earnings at $7.14 EPS and FY2020 earnings at $10.51 EPS.

  • [By Stephan Byrd]

    Nexstar Media Group (NASDAQ:NXST) had its price target cut by B. Riley to $87.00. They currently have a buy rating on the stock.

    Ralph Lauren (NYSE:RL) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Ralph Lauren outperformed the industry in the past six months backed by robust bottom-line performance in recent quarters. Notably, third-quarter fiscal 2018 marked the company’s 12th consecutive earnings beat while sales lagged estimates after a beat in the previous quarter. Additionally, the company’s Way Forward Plan is on track, and it remains keen on bolstering digital and international presence. Also, the company has been gaining from favorable geographic and channel mix shifts along with lower promotions and reduced product costs. Further, management adjusted fiscal 2018 outlook to account for the positive currency rates, which are likely to aid revenues and operating margins. However, its North America business continues to suffer due to distribution and brand exits, planned reduction in shipments and promotions to enhance the quality of sales, and lower customer demand.”

Best Small Cap Stocks To Own Right Now: Heritage-Crystal Clean, Inc.(HCCI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Heritage-Crystal Clean (HCCI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Heritage-Crystal Clean (HCCI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Heritage-Crystal Clean (HCCI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Heritage Crystal Clean (HCCI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Small Cap Stocks To Own Right Now: Books-A-Million Inc.(BAMM)

Advisors’ Opinion:

  • [By Joseph Griffin]

    News articles about Books-A-Million (NASDAQ:BAMM) have trended positive recently, according to Accern. The research group rates the sentiment of news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Books-A-Million earned a coverage optimism score of 0.27 on Accern’s scale. Accern also gave news articles about the specialty retailer an impact score of 44.3915244007427 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Top 10 Blue Chip Stocks To Invest In 2019

U.K. stocks on Wednesday wavered, with the International Monetary Fund set to offer its assessment of the British economy, but blue chips remained close to a six-week high.

London-listed shares were lower alongside other global markets, which were unable to gain much traction after U.S. lawmakers made a major push forward into overhauling the countrys tax code.

How markets are moving: The FTSE 100 index
UKX, -0.13%
was up 1 point at 7,545.46 after dipping into negative territory. The basic materials and health care groups were gaining the most, but consumer goods and utilities were among the sector that fell. On Tuesday, the index rose 0.1% and marked it best close since Nov. 6.

Top 10 Blue Chip Stocks To Invest In 2019: Hibbett Sports Inc.(HIBB)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Hibbett Sports, Inc. (NASDAQ:HIBB) dropped 15.6% during trading on Friday after the company announced weaker than expected quarterly earnings. The company traded as low as $24.37 and last traded at $24.42. Approximately 4,029,500 shares changed hands during trading, an increase of 424% from the average daily volume of 769,435 shares. The stock had previously closed at $28.95.

  • [By Garrett Baldwin]

    We’re about to reveal a little wealth secret that could unlock the trade of a lifetime.Money MorningSpecial Situation Strategist Tim Melvin takes you inside what could easily be a 10-bagger for investors in the weeks ahead.Read more right here.

    The Top Stock Market Stories for Friday
    Meanwhile, the United States will continue to meet with China to discuss ways to accelerate a deal between the two nations on trade. U.S. Commerce head Wilbur Ross will be visiting the nation next month to lead the next round of talks. Last weekend, the two nations agreed in principle to avoid a trade war. Here’s the thing… the U.S. government doesn’t want you to know the full story of what is happening. Here’s a look at the backroom details…. U.S. crude oil prices slumped below $70 per barrel Friday thanks to reports out of Russia on its plans to hike production. Russia says it may increase production as part of a plan to ease portions of its deal with OPEC to cap excessive global output. Oil traders have long suspected that Russia would be one of the first countries to turn away from the ongoing deal with Saudi Arabia and the rest of the global oil cartel as soon as prices and inventory levels stabilized. This could be a blow to predictions among OPEC nations, as well as some traders who were hoping that oil could push back toward $100 per barrel.
    Three Stocks to Watch Today: FL, NFLX, AMZN
    Foot Locker Inc.(NYSE: FL) leads a light day of earnings reports. Shares of the shoe retailer popped 13% after the firm reported earnings per share (EPS) of $1.45. Wall Street had anticipated EPS of just $1.24. The retailer benefited from stronger same-store sales and higher revenue, which also beat Wall Street expectations. On Thursday, Netflix Inc. (Nasdaq: NFLX) surpassed The Walt Disney Co.(NYSE: DIS) in market capitalization to become the most valuable media property on the planet. It’s worth noting, however, that Netflix’s market capitalization of $163 billion

  • [By Motley Fool Staff]

    Hibbett Sports (NASDAQ:HIBB) Q1 2019 Earnings Conference CallMay. 25, 2018 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Lisa Levin]

    Hibbett Sports, Inc. (NASDAQ: HIBB) was down, falling around 15 percent to $24.60 after the company reported weaker-than-expected results for its first quarter.

  • [By Shane Hupp]

    Trexquant Investment LP acquired a new stake in shares of Hibbett Sports (NASDAQ:HIBB) during the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 12,159 shares of the company’s stock, valued at approximately $291,000.

  • [By Timothy Green]

    Shares of Hibbett Sports (NASDAQ:HIBB) slumped on Friday after the retailer reported lackluster first-quarter results. Hibbett missed analyst expectations across the board, with strong e-commerce sales unable to offset a decline in comparable-store sales. The stock was down about 13.8% at 11:25 a.m. EDT.

Top 10 Blue Chip Stocks To Invest In 2019: Simulations Plus, Inc.(SLP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Simulations Plus (NASDAQ: SLP) and Cerner (NASDAQ:CERN) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, dividends, earnings and risk.

  • [By Stephan Byrd]

    Simulations Plus (NASDAQ:SLP) shares hit a new 52-week high and low during mid-day trading on Monday . The company traded as low as $18.55 and last traded at $18.35, with a volume of 49668 shares changing hands. The stock had previously closed at $18.20.

  • [By Stephan Byrd]

    Mattersight (NASDAQ: MATR) and Simulations Plus (NASDAQ:SLP) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings and analyst recommendations.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Simulations Plus (SLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    BidaskClub upgraded shares of Simulations Plus (NASDAQ:SLP) from a buy rating to a strong-buy rating in a research note published on Wednesday morning.

Top 10 Blue Chip Stocks To Invest In 2019: Aqua America, Inc.(WTR)

Advisors’ Opinion:

  • [By ]

    Aqua America (WTR) : “This is not the stock for a hot economy, even though this is a well-run company.”

    Mueller Water Products (MWA) : “This is not the time to buy. I don’t like the numbers.”

  • [By Shane Hupp]

    Duff & Phelps Investment Management Co. reduced its stake in shares of Aqua America (NYSE:WTR) by 7.1% during the first quarter, Holdings Channel reports. The institutional investor owned 95,640 shares of the utilities provider’s stock after selling 7,290 shares during the quarter. Duff & Phelps Investment Management Co.’s holdings in Aqua America were worth $3,257,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    ValuEngine upgraded shares of Aqua America (NYSE:WTR) from a hold rating to a buy rating in a report released on Friday.

    Several other analysts also recently weighed in on the stock. Zacks Investment Research upgraded shares of Aqua America from a hold rating to a buy rating and set a $41.00 price objective on the stock in a research report on Monday, January 15th. Wells Fargo downgraded shares of Aqua America from an outperform rating to a market perform rating and dropped their price target for the stock from $43.00 to $37.00 in a research report on Monday, February 26th. UBS began coverage on shares of Aqua America in a research report on Thursday, March 8th. They set a neutral rating and a $36.00 price target on the stock. Finally, Boenning Scattergood restated a neutral rating on shares of Aqua America in a research report on Tuesday, April 24th. Seven equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company presently has a consensus rating of Hold and a consensus target price of $38.29.

  • [By Joseph Griffin]

    Aqua America (NYSE: WTR) and SJW Group (NYSE:SJW) are both utilities companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk.

  • [By Maxx Chatsko]

    Will that be enough to earn its relatively expensive valuation? Perhaps, although analysts aren’t expecting Aqua America to grow nearly as quickly as some of its peers. That’s evidenced by comparing the company to both its larger peer American Water Works and smaller regional peer California Water Services Group.

    Company Market Cap Dividend Yield Forward P/E Ratio PEG Ratio Enterprise Value-to-EBITDA Ratio
    Aqua America (NYSE:WTR) $6.2 billion 2.4% 23.3 5.05 18
    American Water Works $14.9 billion 2.1% 23.4 3.14 13.2
    California Water Services Group $1.9 billion 1.9% 27 3.02 12.6

    Data source: Yahoo! Finance.

Top 10 Blue Chip Stocks To Invest In 2019: Heritage-Crystal Clean, Inc.(HCCI)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Heritage Crystal Clean (HCCI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Heritage-Crystal Clean (HCCI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Blue Chip Stocks To Invest In 2019: Tanger Factory Outlet Centers Inc.(SKT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Tanger Factory Outlet Centers (SKT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Matthew Frankel]

    Tanger Factory Outlet Centers (NYSE:SKT) has performed quite poorly lately. After a 7% drop following its first-quarter earnings release, the stock has now underperformed the S&P 500 by a staggering 69 percentage points over the past two years.

  • [By Paul Ausick]

    Tanger Factory Outlet Centers Inc. (NYSE: SKT) traded down nearly 10% Wednesday and posted a new 52-week low of $21.14 after closing Tuesday at $23.47. The stock’s 52-week high is $34.76. Volume was around 6.9 million, nearly five times the daily average. The companr reported results after markets closed Tuesday.

  • [By Leo Sun]

    Shares of Tanger Factory Outlets (NYSE:SKT) fell 9% to an eight-year low on May 2 after the outlet owner reported itsfirst quarter earnings. Tanger beat estimates on the top and bottom lines, but also reported declines in its core business and cut its full-year guidance.

  • [By Jeremy Bowman, Leo Sun, and Steve Symington]

    To take advantage of that potential boom, we asked three of our retail writers for their top picks for May. See why they recommend Dollar General (NYSE:DG), Tanger Factory Outlet Centers (NYSE:SKT), and Home Depot (NYSE:HD).

Top 10 Blue Chip Stocks To Invest In 2019: Castle Brands, Inc.(ROX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Castle Brands (NYSEAMERICAN:ROX) was the recipient of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 6,422,984 shares, a decrease of 5.8% from the April 30th total of 6,815,151 shares. Based on an average daily volume of 169,266 shares, the short-interest ratio is presently 37.9 days. Currently, 7.2% of the company’s stock are sold short.

Top 10 Blue Chip Stocks To Invest In 2019: Empire Resorts Inc.(NYNY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Wendys (NASDAQ: WEN) and Empire Resorts (NASDAQ:NYNY) are both retail/wholesale companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.

Top 10 Blue Chip Stocks To Invest In 2019: Canadian Pacific Railway Limited(CP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Canadian Pacific Railway (TSE:CP) (NYSE:CP) had its target price boosted by BMO Capital Markets from C$254.00 to C$265.00 in a research note published on Thursday morning.

  • [By Stephan Byrd]

    These are some of the media stories that may have impacted Accern Sentiment’s analysis:

    Get Canadian Pacific Railway alerts:

    UPDATE 3-Canadian Pacific workers strike, putting industries in disarray (reuters.com) CP’s Executive Vice-President and Chief Financial Officer to address the UBS Global Industrials and Transportation Conference on June 13, 2018 (finance.yahoo.com) Canadian Pacific Railway (CP) Receives Consensus Recommendation of “Buy” from Analysts (americanbankingnews.com) Canadian Pacific train crews strike; deal done with signalers (platts.com) More Than 3,000 Train Operators at Canadian Pacific Rail on Strike (theepochtimes.com)

    Several equities analysts recently issued reports on CP shares. Cowen reiterated an “outperform” rating and set a $209.00 price target (up previously from $207.00) on shares of Canadian Pacific Railway in a research report on Wednesday, February 28th. Zacks Investment Research cut shares of Canadian Pacific Railway from a “hold” rating to a “sell” rating in a research report on Tuesday, March 27th. Morgan Stanley reduced their price target on shares of Canadian Pacific Railway from $248.00 to $243.00 and set an “overweight” rating on the stock in a research report on Friday, April 6th. Credit Suisse Group reiterated an “outperform” rating and set a $200.00 price target (down previously from $209.00) on shares of Canadian Pacific Railway in a research report on Thursday, March 8th. Finally, Goldman Sachs Group upgraded shares of Canadian Pacific Railway from a “neutral” rating to a “buy” rating and boosted their price target for the company from $176.72 to $213.00 in a research report on Tuesday, February 13th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and twelve have given a buy rating to the company’s stock. The company ha

  • [By Stephan Byrd]

    Canadian Pacific Railway Limited (NYSE:CP) (TSE:CP) – Research analysts at National Bank Financial lowered their Q3 2018 earnings estimates for Canadian Pacific Railway in a report released on Wednesday, June 20th. National Bank Financial analyst C. Doerksen now anticipates that the transportation company will post earnings of $2.51 per share for the quarter, down from their previous forecast of $2.62. National Bank Financial also issued estimates for Canadian Pacific Railway’s Q4 2018 earnings at $2.76 EPS, FY2018 earnings at $9.56 EPS and FY2019 earnings at $10.84 EPS.

  • [By Tyler Crowe]

    After an incredible fourth quarter,the first quarter of 2018 wasn’tCanadian Pacific’s (NYSE:CP) finest showing. While carloads and revenue continue to increase, operating costs are growing faster. If that weren’t enough of a concern, management has been notified that its union workers intend to strike in the coming days.

Top 10 Blue Chip Stocks To Invest In 2019: NetApp Inc.(NTAP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Lowe's Companies, Inc. (NYSE: LOW) to report quarterly earnings at $1.25 per share on revenue of $17.63 billion before the opening bell. Lowe's shares declined 0.35 percent to $85.45 in pre-market trading.
    Analysts expect NetApp, Inc. (NASDAQ: NTAP) to post quarterly earnings at $1.01 per share on revenue of $1.60 billion after the closing bell. NetApp shares dropped 2.09 percent to close at $67.02 on Tuesday.
    Urban Outfitters, Inc. (NASDAQ: URBN) reported better-than-expected earnings for its fiscal first quarter on Tuesday. Urban Outfitters shares dropped 2.21 percent to $40.30 in the pre-market trading session.
    Before the markets open, Tiffany & Co. (NYSE: TIF) is projected to report quarterly earnings at $0.83 per share on revenue of $957.49 million. Tiffany shares gained 0.45 percent to $102.70 in pre-market trading.
    Analysts are expecting Target Corporation (NYSE: TGT) to have earned $1.38 per share on revenue of $16.50 billion in the latest quarter. Target will release earnings before the markets open. Target shares rose 0.07 percent to $75.52 in pre-market trading.
    Hewlett Packard Enterprise Co (NYSE: HPE) reported stronger-than-expected profit for its fiscal second quarter and raised its FY18 GAAP earnings outlook. Hewlett Packard Enterprise shares rose 0.40 percent to $17.48 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Max Byerly]

    Amundi Pioneer Asset Management Inc. lifted its holdings in NetApp Inc. (NASDAQ:NTAP) by 22.3% in the 1st quarter, HoldingsChannel.com reports. The firm owned 381,020 shares of the data storage provider’s stock after acquiring an additional 69,530 shares during the quarter. Amundi Pioneer Asset Management Inc.’s holdings in NetApp were worth $23,505,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    NetApp (NASDAQ:NTAP) received a $83.00 price objective from DA Davidson in a research note issued on Thursday. The brokerage presently has a “buy” rating on the data storage provider’s stock. DA Davidson’s price target would suggest a potential upside of 23.60% from the company’s current price. DA Davidson also issued estimates for NetApp’s Q1 2019 earnings at $0.66 EPS, Q2 2019 earnings at $0.75 EPS, Q4 2019 earnings at $0.88 EPS, FY2019 earnings at $3.11 EPS, Q1 2020 earnings at $0.80 EPS, Q2 2020 earnings at $0.86 EPS, Q3 2020 earnings at $0.94 EPS, Q4 2020 earnings at $1.03 EPS and FY2020 earnings at $3.65 EPS.

  • [By Garrett Baldwin]

    Markets have been under pressure once again by the U.S. Federal Reserve. Inflation levels are going through the roof… but the people in charge of managing it have been lying to Americans for years. Now it’s time to get even.Money MorningLiquidity Specialist Lee Adler has the perfect way to make a lot of money when no one is looking.Read it here.

    The Top Stock Market Stories for Wednesday
    In addition to Trump’s concerns about China and trade, the President also stated that he is unsure whether a summit with North Korean leader Kim Jong-Un will take place as planned. Multiple media outlets this morning are questioning if the event will take place. The summit is tentatively planned for June 12. Banking stocks were on the move after Congress passed new laws designed to reduce regulations for thousands of financial institutions. The new rules will ensure that smaller banks are not facing the same strict rules as the bigger giants. The financial sector has been lobbying to changes to the Dodd-Frank Act since its inception after the 2008-09 financial crisis. Facebook Inc. (Nasdaq: FB) CEO Mark Zuckerberg met with members of the European Union on Tuesday. The CEO of the social media giant outraged European Parliament members after reportedly dodging questions about user privacy and the firm’s collection of personal data. During the conversation, EU members questioned whether Facebook is a monopoly and pondered if the firm should be broken up due to antitrust concerns.
    Three Stocks to Watch Today: TGT, LOW, TIF
    Shares of Target Corporation (NYSE: TGT) fell nearly 6% after the retail giant fell short of earnings expectations before the bell. The firm reported earnings per share of $1.32. This figure missed Wall Street earnings expectations by six cents. The retail giant blamed poor spring weather for its performance and said that its bottom line has been impacted by the costs of upgrading its physical locations. Lowe’s Companies (NYSE: LOW) stock gained

  • [By Logan Wallace]

    Pivotal Research set a $74.00 price target on NetApp (NASDAQ:NTAP) in a research note released on Wednesday, Marketbeat Ratings reports. The brokerage currently has a buy rating on the data storage provider’s stock.

Top 10 Blue Chip Stocks To Invest In 2019: Catabasis Pharmaceuticals, Inc.(CATB)

Advisors’ Opinion:

  • [By Max Byerly]

    These are some of the news articles that may have effected Accern’s analysis:

    Get Catabasis Pharmaceuticals alerts:

    Market Trends Toward New Normal in Church & Dwight Co., Rent-A-Center, Teradata, Catabasis Pharmaceuticals, Tronox, and Callaway Golf Emerging Consolidated Expectations, Analyst Ratings (finance.yahoo.com) Catabasis Pharmaceuticals Inc. – Receive News & Ratings Daily (thecasualsmart.com) Catabasis Pharmaceuticals (CATB) Upgraded by ValuEngine to Sell (americanbankingnews.com) Catabasis Pharmaceuticals to Report First Quarter 2018 Financial Results and Recent Corporate Developments on Thursday, May 10 (finance.yahoo.com) Catabasis Pharmaceuticals Inc (CATB) Given Consensus Rating of “Buy” by Brokerages (americanbankingnews.com)

    A number of analysts recently issued reports on CATB shares. Zacks Investment Research raised Catabasis Pharmaceuticals from a “hold” rating to a “buy” rating and set a $1.75 target price on the stock in a research report on Friday, January 26th. Wedbush reaffirmed an “outperform” rating and issued a $4.00 target price (down previously from $5.00) on shares of Catabasis Pharmaceuticals in a research report on Wednesday, February 14th. Finally, ValuEngine raised Catabasis Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research report on Wednesday, May 2nd. One analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the stock. Catabasis Pharmaceuticals presently has a consensus rating of “Buy” and a consensus target price of $5.18.

  • [By Ethan Ryder]

    Press coverage about Catabasis Pharmaceuticals (NASDAQ:CATB) has been trending somewhat positive recently, according to Accern. The research firm identifies negative and positive press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Catabasis Pharmaceuticals earned a media sentiment score of 0.05 on Accern’s scale. Accern also assigned news articles about the biotechnology company an impact score of 44.9364257314523 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.